Table 3.
Baseline laboratory parameters in endometrial cancer patients divided according to tumor type.
| Parameter | Type I Cancer (G1–G2 Endometrioid) N = 203 |
Type II Cancer (Non-Endometrioid and G3 Endometrioid) N = 102 |
p-Value | 95% CI |
|---|---|---|---|---|
| Leptin, ng/mL (mean ± SD) | 58.5 ± 18 | 18.3 ± 9.6 | <0.0001 | −43.18 to −24.19 |
| IL-6, pg/mL (mean ± SD) | 24.1 ± 11.5 | 18.3 ± 10.7 | <0.0001 | −28.1 to −11.9 |
| TNF-α, pg/mL (mean ± SD) | 18.7 ± 9.8 | 22.1 ± 10.2 | 0.1650 | −11.76 to 2.678 |
| ROS, FORT U (mean ± SD) | 497 ± 152 | 397 ± 98 | <0.0001 | −89.98 to −35.4 |
| GPx, U/mL (mean ± SD) | 8165 ± 2590 | 7464 ± 1228 | 0.1357 | −25.16 to 15.3 |
| SOD, U/L (mean ± SD) | 108 ± 49 | 117 ± 67 | 0.3272 | −28.7 to 16.7 |
p-value was calculated by Student’s t-test. p-value < 0.05 is considered significant (bold value). Abbreviations: SD, standard deviation; IL, interleukin; TNF, tumor necrosis factor; ROS, reactive oxygen species; GPx, glutathione peroxidase; SOD, superoxide dismutase.